Clinical Trial Update: CAR T Cells in Patients With MMP2+ Recurrent or Progressive Glioblastoma [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating CAR T cells targeting MMP2 in patients with recurrent or progressive glioblastoma; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• CAR T cells targeting MMP2 (Chimeric antigen receptor T-cell therapy targeting MMP2)

Snippet

Sponsor: Chimeric Therapeutics | Conditions: Glioblastoma Multiforme of Brain | Phase 1 | Status: ACTIVE_NOT_RECRUITING